Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
The role of the mesenchymal stromal cell- (MSC-) derived secretome is becoming increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous tissue repair processes as well as its effective regulation of the immune system, mimicking the therapeutic effects produced by the MSCs. The secretome is a composite product secreted by MSC in vitro (in conditioned medium) and in vivo (in the extracellular milieu), consisting of a protein soluble fraction (mostly growth factors and cytokines) and a vesicular component, extracellular vesicles (EVs), which transfer proteins, lipids, and genetic material. MSC-derived secretome differs based on the tissue from which the MSCs are isolated and under specific conditions (e.g., preconditioning or priming) suggesting that clinical applications should be tailored by choosing the tissue of origin and a priming regimen to specifically correct a given pathology. MSC-derived secretome mediates beneficial angiogenic effects in a variety of tissue injury-related diseases. This supports the current effort to develop cell-free therapeutic products that bring both clinical benefits (reduced immunogenicity, persistence in vivo , and no genotoxicity associated with long-term cell cultures) and manufacturing advantages (reduced costs, availability of large quantities of off-the-shelf products, and lower regulatory burden). In the present review, we aim to give a comprehensive picture of the numerous components of the secretome produced by MSCs derived from the most common tissue sources for clinical use (e.g., AT, BM, and CB). We focus on the factors involved in the complex regulation of angiogenic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The overall presence and concentration of angiogenic factors within the CM were found to be superior in BM preparations with increased relative levels of tubulogenesis-driving factors such as VEGF [39, 40].”
From Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach (2023) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gong, X., Liu, H., Wang, S., Liang, S., & Wang, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28070 · Cited by 140
RetractedMultilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 2×
“To differentiate MSCs from other morphologically similar cells, the International Society for Cellular Therapy (ISCT) defined the minimal set of criteria by which MSCs are identified: adherence to plastic under normal cell culture conditions; differentiation capability into multiple cell lineages including, and not li…”
BackgroundThéry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · cited 1×
“quality/purity of isolated EVs in order to confidently report biological cargo or functions to EVs [38].”
BackgroundCaplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186 · cited 2×
“Cells secrete a wide range of EVs that differ in size, origin, content, and function [37].”
BackgroundMesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746 · cited 1×
“As an example, MSCs can differentiate into endotheliocytes and myocytes in the mesoderm under conditional induction [84].”
BackgroundCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444 · cited 2×
“Recently, it has become apparent that secreted EVs are proficient intercellular communication mediators through the transfer of their cargo to target cells and their ability to influence the behavior of recipient cells [36].”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“While it was initially conceived that MSCs exerted their therapeutic effects by migrating to targeted sites of injury and actively contributed to tissue repair and regeneration, it is now increasingly acknowledged that MSCs do not typically engraft after transplantation, due to the phenomena of lung sequestration and…”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“Mesenchymal stromal cells (MSCs) were described for the first time in 1970 by Alexander Friedenstein as a “population of bone marrow stromal cells capable of mesodermal differentiation and trophic support of hematopoiesis” [1, 2].”
Background
Cited by
Items 101–200 of 278
Mesenchymal stem cells for enhancing biological healing after meniscal injuries
Rhim, H. C., Jeon, O. H., Han, S.-B., Bae, J., Suh, D. W., & Jang, K.-M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i8.1005 · Cited by 15
Keklık, M., Devecı, B., Çelik, S., Denız, K., Gönen, Z. B., Zararsız, G., Saba, R., Akyol, G., Özkul, Y., Kaynar, L., et al. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05216-3 · Cited by 15
Hodge, J., Robinson, J. L., & Mellott, A. J. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00565-6 · Cited by 17
“To date, the secretome of MSC-like populations have been shown to stimulate a variety of wound healing functions, including modulation of fibrotic activity in fibroblasts [41], promotion of angiogenic activity in endothelial cells [42], and increased keratinocyte migratory activity [43].”
BackgroundLin, J., Yang, Z., Wang, L., Xing, D., & Lin, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.956058 · Cited by 14
“At present, more and more studies have showed that stem cells are considered to exhibit their therapeutic effect in a paracrine manner and extracellular vesicles (EVs) play a pivotal role in this manner (Liang et al., 2014; Maacha et al., 2020).”
BackgroundFunctional variation among mesenchymal stem cells derived from different tissue sources
Yi, N., Zeng, Q., Zheng, C., Li, S., Lv, B., Wang, C., Li, C., Jiang, W., Liu, Y., Yang, Y., et al. (2024) · PeerJ · doi:10.7717/peerj.17616 · Cited by 14
“MSCs have pro-angiogenic potential via paracrine signaling and angiogenic growth factors ( Bronckaers et al., 2014 ; Liao et al., 2009 ; Maacha et al., 2020 ).”
Chen, X., Chen, Y.-Y., Lin, W., Chen, C.-H., Wen, Y.-C., Hsiao, T.-C., Chou, H., Chung, K. F., & Chuang, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.713824 · Cited by 15
“Also, tissue-repair actions of MSCs through a paracrine mechanism were explored (9, 10).”
BackgroundChen, K., Obara, H., Matsubara, Y., Fukuda, K., Yagi, H., Ono‐Uruga, Y., Matsubara, K., & Kitagawa, Y. (2022) · Cell Transplantation · doi:10.1177/09636897221089629 · Cited by 14
Singh, A. K., Khanal, N., & Chaulagain, R. (2022) · International Journal of Dentistry · doi:10.1155/2022/9696378 · Cited by 14
“'ey are said to exert the paracrine effect and also play an important role in transfer of protein, lipid, and genetic material to the recipient cells [52].”
Desai, S., Sharma, D., Srinivas, R., Balaji, V., Thakore, V., Bedi, V. S., Jindal, R., Sugumaran, A., Mohanasundaram, S., Gogtay, J. A., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03957-0 · Cited by 14
Eshraghi, A. A., Ocak, E., Zhu, A., Mittal, J., Davies, C., Shahal, D., Bulut, E., Sinha, R., Shah, V., Perdomo, M. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061711 · Cited by 14
Rofaani, E., Mardani, M. W., Yutiana, P. N., Amanda, O., & Darmawan, N. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09743-8 · Cited by 16
“The injury in vascular tissue is related to cardiovascular disease (CVD), spinal cord injury (SCI), diabetic wound, pre-eclampsia, and others [10].”
Adib, F. R., Bagheri, F., & Sharifi, A. M. (2022) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35063 · Cited by 13
Ramakrishnan, P., Jalaludeen, A. M., Vinayagam, S., Gnanasekaran, L., Thirumurugan, D., Rajamohan, R., & Sundaram, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147919 · Cited by 13
Kim, Y., Lee, S. H., Im, J., Song, J., Kim, H. Y., & Bhang, S. H. (2022) · Communications Biology · doi:10.1038/s42003-022-03838-3 · Cited by 12
Todorova, V., Baxan, N., Delahaye, M. W., Harding, S. E., & Rankin, S. M. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049630 · Cited by 13
Effect of stem cell secretome in skin rejuvenation: a narrative review
Hani, R., Khayat, L., Rahman, A. A., & Alaaeddine, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08622-y · Cited by 13
“Both stem cells as well as their secretome have major roles in inducing angiogenesis in vivo and in vitro [58].”
BackgroundPark, N., Kim, K. S., & Na, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.011 · Cited by 13
Azlan, N. A. B. N., Vitus, V., Rashid, N. N., Nordin, F., Tye, G. J., & Zaman, W. S. W. K. (2024) · Cell and Tissue Research · doi:10.1007/s00441-023-03857-4 · Cited by 14
Current status of myocardial restoration via the paracrine function of mesenchymal stromal cells
Nguyen‐Truong, M., Hematti, P., & Wang, Z. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00217.2021 · Cited by 16
Davletshin, E. F., Sabirov, D., Rizvanov, A. A., & Mukhamedshina, Y. O. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2712334 · Cited by 12
“The therapeutic effect of these cells is due to their paracrine mechanism of action [55,56].”
BackgroundKrupczak, B., Farruggio, C. C., & Vliet, K. J. V. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05373-7 · Cited by 11
Humeník, F., Maloveská, M., Hudáková, N., Petroušková, P., Šufliarska, Z., Horňáková, Ľ., Valenčáková, A., Kožár, M., Šišková, B., Mudroňová, D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098214 · Cited by 11
“The mechanism of influencing angiogenesis is conditioned by the production of enzymes (PKA), the activation of some metabolic pathways (MAPK, PI3K/Akt), and the growth factors IGF-1, VEGF, von Willebrand factor, PDGF, PLGF, and TGF-ß [11].”
BackgroundThe role of Wnt signaling in mesenchymal stromal cell-driven angiogenesis
Mankuzhy, P. D., Dharmarajan, A., Perumalsamy, L. R., Sharun, K., Samji, P., & Dilley, R. J. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102240 · Cited by 12
Uwazie, C. C., Pirlot, B. M., Faircloth, T. U., Patel, M., Parr, R. N., Zastre, H. M., Hematti, P., Moll, G., Rajan, D., & Chinnadurai, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1214098 · Cited by 10
“MSCs have the propensity to drive angiogenesis as part of their repair and regenerative properties (57, 58).”
BackgroundTejedor, S., Buigues, M., González‐King, H., da Silva, A. M., García, N. A., Dekker, N., & Sepúlveda, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076467 · Cited by 10
Kaokaen, P., Pangjantuk, A., Kunhorm, P., Promjantuek, W., Chaicharoenaudomrung, N., & Noisa, P. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105973 · Cited by 10
Comprehensive Comparison of Amnion Stromal Cells and Chorion Stromal Cells by RNA-Seq
Jones, B., Li, C., Park, M. S., Lerch, A., Jacob, V., Johnson, N., Kuang, J.-Q., Dhall, S., & Sathyamoorthy, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041901 · Cited by 11
Muñiz-García, A., Wilm, B., Murray, P. A., & Cross, M. J. (2022) · Cells · doi:10.3390/cells11233750 · Cited by 11
IL-1b in the Secretomes of MSCs Seeded on Human Decellularized Allogeneic Bone Promotes Angiogenesis
Chen, Y., Fu, Y.-S., Tsai, S., Wu, P., Chen, C.-M., Chen, W., & Chen, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315301 · Cited by 10
Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke Research
Zheng, X., Haupt, M., Bähr, M., Tatenhorst, L., & Doeppner, T. R. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.cerebralischemia.2021.therapy · Cited by 12
“Cytokines that are related to angiogenesis, such as vascular endothelial growth factor-A (VEGF-A) and VEGF-C, are enriched in MSC-EVs as well (123).”
Roy, M.-È., Veilleux, C., & Annabi, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-72862-6 · Cited by 9
“After their mobilization and tissue engraftment, MSC-derived secretome then appears to mediate the different steps of the angiogenic process, inducing endothelial cell functions in vitro and promoting angiogenesis in vivo 4 .”
BackgroundSanz‐Nogués, C., Keane, A. J., Creane, M., Hynes, S. O., Chen, X., Lyons, C. J., Horan, E., Elliman, S. J., Goljanek‐Whysall, K., & O’Brien, T. (2024) · Stem Cells · doi:10.1093/stmcls/sxae058 · Cited by 9
Hagen, A., Niebert, S., Brandt, V.-P., Holland, H., Melzer, M., Wehrend, A., & Burk, J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.890302 · Cited by 11
“The paracrine factors involved in angiogenesis are HGF, VEGF, basic fibroblast growth factor (bFGF), transforming growth factor-β (TGF-β) and Ang-1 (61, 69).”
BackgroundAjit, A., Kumar, T. R. S., Harikrishnan, V. S., Anil, A., Sabareeswaran, A., & Krishnan, L. K. (2023) · 3 Biotech · doi:10.1007/s13205-023-03496-0 · Cited by 11
“Reports state that ADMSC secretome presents a better tubulogenic competence compared to BM-MSCs due to their higher expression of angiogenic factors (Maacha et al. 2020).”
BackgroundGordon, J. A. R., Evans, M. F., Ghule, P. N., Lee, K., Vacek, P. M., Sprague, B. L., Weaver, D. L., Stein, G. S., & Stein, J. L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282473 · Cited by 9
“MSCs are a primary source of proangiogenic cytokines due to their role in normal tissue repair [64, 65].”
BackgroundThe potential role of mesenchymal stem cells in modulating antiageing process
Govindasamy, V., Rajendran, A., LEE, Z., Ooi, G., Then, K.-Y., Then, K., Gayathri, M., Das, A. K., & Cheong, S. (2021) · Cell Biology International · doi:10.1002/cbin.11652 · Cited by 9
“These biomolecules include growth factors, cytokines and extracellular vehicles, which transfer proteins, lipids, and genetic material to | 2003 recipient cells (Maacha et al., 2020).”
BackgroundWan, J., Wu, T., Wang, K., Xia, K., Yin, L., & Chen, C. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb01389d · Cited by 10
Kim, H. Y., Yoon, H.-S., Lee, Y., Kim, Y., Cho, K., Woo, S., Kim, H. S., Ryu, K., & Park, J. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00501-0 · Cited by 8
“Conditioned medium (CM) derived from MSCs exerts therapeutic effects similar to those of MSCs [30].”
BackgroundLight‐emitting Diode Can Enhance the Metabolism and Paracrine Action of Mesenchymal Stem Cells
Mansano, B. S. D. M., da Rocha, V. P., Teixeira, I. L. A., de Oliveira, H. A., Vieira, S. S., Antônio, E. L., Tucci, P. J. F., & Serra, A. J. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13794 · Cited by 8
“Paracrine effects of the MSCs playing a decisive role in the success of cell therapy (10,36).”
BackgroundVascular Progenitor Cells: From Cancer to Tissue Repair
Barachini, S., Ghelardoni, S., & Madonna, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062399 · Cited by 8
“It is now increasingly recognized that MSCs typically do not engraft after transplantation and have limited capabilities to trans-differentiate in vivo, but they exhibit their therapeutic effect in a paracrine manner through the secretion of bioactive factors (such as microRNA, transfer RNA, long non-coding RNA, growt…”
BackgroundRomaniyanto, R., Prakoeswa, C. R. S., Tinduh, D., Notobroto, H. B., Rantam, F. A., Utomo, D. N., Suroto, H., & Ferdiansyah, F. (2021) · Indonesian Journal of Biotechnology · doi:10.22146/ijbiotech.63318 · Cited by 9
“Recent studies reported that the beneficial angiogenic effects of MSCs are me diated by their secretome (Maacha et al. 2020).”
BackgroundInfluentialŠkovroňová, R., Scaccia, E., Calcat-i-Cervera, S., Bussolati, B., O’Brien, T., & Bieback, K. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04602-9 · Cited by 8
“On the other hand, the protein-rich fraction of the secretome includes different growth factors and cytokines with key roles in the regenerative activity such as vascular endothelial growth factor (VEGF), transforming growth factor β (TGF-β), or hepatocyte growth factor (HGF), among others [9, 10].”
BackgroundEnhancing angiogenesis through secretomes: Insights from scratch wound assay
Shekatkar, M., Kheur, S. M., Deshpande, S., Sakhare, S., Sanap, A. P., Kharat, A. H., & Bhonde, R. R. (2025) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2025.05.008 · Cited by 7
“21 The dual mechanism of action, which involves the direct stimulation of endothelial cells alongside the modulation of the immune microenvironment, positions MSC secretomes as particularly advantageous for applications in wound healing, cardiovascular pathologies, and diabetic ulcer management.”
Kawasumi, R., Kawamura, T., Yamashita, K., Tominaga, Y., Harada, A., Ito, E., Takeda, M., Kita, S., Shimomura, I., & Miyagawa, S. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.12.008 · Cited by 7
“Moreover, EVs released from MSCs have a paracrine effect on surrounding tissues; therefore, locally accumulated MSCs would release EVs and carry angiogenetic and anti-fi brotic effects to adjacent myocardium and other cells [35].”
CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration
Hsieh, C.-C., Hsu, S.-C., Yao, M., & Huang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041738 · Cited by 7
“In addition, MSC-derived EVs exert beneficial effects on a number of tissue-injury-related diseases [11].”
BackgroundStandardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model
Wolint, P., Hofmann, S., von Atzigen, J., Böni, R., Miescher, I., Giovanoli, P., Calcagni, M., Emmert, M. Y., & Buschmann, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010291 · Cited by 8
Carmona-Luque, M., Ballesteros-Ribelles, A., Millán-López, A., Blanco, A., Nogueras, S., & Herrera, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092480 · Cited by 6
Role of stem cells in ageing and age-related diseases
Chaudhary, J. K., Danga, A. K., Kumari, A., Bhardwaj, A., & Rath, P. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112069 · Cited by 7
Xu, J., Chen, C., Gan, S., Liao, Y., Fu, R., Hou, C., Yang, S., Zheng, Z., & Chen, W. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-09027-7 · Cited by 6
“…can secrete cytokines such as HGF, SCF, BMP-2, platelet-derived growth factor (PDGF), placental growth factor (PIGF), IL-6, and monocyte chemoattractant protein 1 (MCP-1), thereby promoting the osteogenic differentiation of osteoblasts or the angiogenesis capacity of endothelial cells [28, 48–50].”
Lei, W., Wang, X., Cai, J., & Pan, L. (2025) · Biotechnology Journal · doi:10.1002/biot.70152 · Cited by 6
“Key paracrine mediators include vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 (SDF-1), insulin-like growth factor-1 (IGF-1), angiopoietin-1, hepatocyte growth factor (HGF), periostin, and thymosin β 4 [91].”
Park, J. S., Kim, D. Y., & Hong, H. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24554 · Cited by 6
Sam, A. D. P., Warsinggih, W., Usman, M. A., Johan, M. P., Suroto, H., Saleh, M. R., Sakti, M., Zainuddin, A. A., & Mubarak, A. F. (2025) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s512079 · Cited by 6
Brembilla, N. C., Modarressi, A., André‐Lévigne, D., Brioudes, E., Lanza, F., Vuagnat, H., Durual, S., Marger, L., Boehncke, W., Krause, K., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030987 · Cited by 7
“produce anti-fibrotic factors [17]; and promote neovascularization [18].”
BackgroundKoh, A. E.-H., Alsaeedi, H. A., Rashid, M. B. A., Lam, C., Harun, M. H. N., Ng, M. H., Isa, H. M., Then, K. Y., Bastion, M.-L. C., Farhana, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652017 · Cited by 6
“Electroretinography is a test that detects electrophysiological responses in the eye under a light stimulus (Marmor et al., 2009).”
BackgroundSecretome, Extracellular Vesicles, Exosomes
Jenner, F., & Ribitsch, I. (2021) · Springer eBooks · doi:10.1007/978-3-030-84744-9_12 · Cited by 6
Hart, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105496 · Cited by 7
“It should also not be forgotten that the progenitor pericytes could also function to maintain the differentiation of the organ-specific endothelial cells of the microvasculature [78].”
BackgroundOliver, A. A., Cortese, J., Ognard, J., Dai, D., Bayraktar, E. A., Ding, Y., Christensen, T. A., Gamb, S. I., Ranatunga, W. K., Carlson, K., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.07.017 · Cited by 5
Roy, A., Driscoll, T. P., Grant, S. C., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110550 · Cited by 5
Stefano, A. B. D., Toia, F., Urrata, V., Trapani, M., Montesano, L., Cammarata, E., Moschella, F., & Cordova, A. (2023) · Gene · doi:10.1016/j.gene.2023.147578 · Cited by 5
de Freitas, F. A., Levy, D., Reichert, C. O., Sampaio‐Silva, J., Giglio, P. N., Lage, L. A. D. P. C., Demange, M. K., Pereira, J. C., & Bydlowski, S. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094748 · Cited by 6
“It is known that some cells can survive to caspase activation when the stimulus is transitory or sublethal [27].”
BackgroundCardiac Repair and Mesenchymal Stem Cells: Exploring New Frontiers in Regenerative Medicine
Nazir, S., Maqbool, T., & Savaş, S. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x376065250728094646 · Cited by 5
“Key factors secreted by MSCs, including vascular endothelial growth factor (VEGF), transforming growth factor (TGF), and matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-14, regulate angiogenesis and enhance endothelial cell survival [36-40].”
Efimenko, A. Y., Kalinina, N., Rubina, K. A., Semina, E. V., Sysoeva, V., Akopyan, Z. A., & Va, T. (2021) · Herald of the Russian Academy of Sciences · doi:10.1134/s101933162102012x · Cited by 5
“Many studies have shown that the different effects of MSCs are due to the components of the secretome—a wide range of soluble biologically active molecules: cytokines, growth factors, enzymes, and factors that regulate inflammation [8, 15].”
BackgroundHopkinson, A., Notara, M., Cursiefen, C., & Sidney, L. E. (2024) · Cell Transplantation · doi:10.1177/09636897241241992 · Cited by 5
“Although the role of these transcription factors is well described in embryonic stem cells, their expression and role in MSCs is not as well-defined and can still be considered controversial 47 .”
BackgroundInfluentialLee, J., Kim, J., Bong, K. W., & Song, S. (2025) · Biomaterials Science · doi:10.1039/d5bm00480b · Cited by 4
Implantation of human mesenchymal stromal cell pellet for therapeutic angiogenesis
Mammoto, A., Kyi, P., Scheer, M., & Mammoto, T. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.102009 · Cited by 4
Lin, S., Tao, C., Wang, Y., Li, J., Shi, Y., Yan, Q., Zhong, Y., Gao, H., Wang, T., Wang, Y., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3089-5 · Cited by 5
Sharma, I., Thakur, R. S., Chaudhary, A. K., Chauhan, R., Singh, K., Sadhu, S., Awasthi, A., & Das, J. B. (2026) · Cell Death Discovery · doi:10.1038/s41420-025-02900-3 · Cited by 4
Dennis, C. J., He, A. Z., Krishnaraj, A., Quan, A., Teoh, H., Connelly, K. A., Hess, D. A., & Verma, S. (2026) · Circulation Research · doi:10.1161/circresaha.126.327425 · Cited by 4
Riordan, N. H., Ambrozic, R. A., & Rodríguez, J. P. (2022) · PubMed Central · Cited by 4
Mazloum, A., Feoktistova, S. G., Gubaeva, A., Alsalloum, A., Mityaeva, O. N., Kim, A., Бодунова, Н. А., Woroncow, M. V., & Volchkov, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168110 · Cited by 4
Yi, J., Lee, S., Ryu, C., Kim, G., Kim, J., & Lee, J. (2025) · MedComm · doi:10.1002/mco2.70352 · Cited by 5
“Inparticular, MSCssecretegrowthfactors,cytokines,andextracellularvesicles, which play important roles in tissue regeneration [8–11].”
THE USE OF STEM CELLS IN THE TREATMENT OF DIABETES
Cui, Y.-X., Shemet, Y. A., & Ziablitsev, S. V. (2023) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2023.16 · Cited by 4
Leone, A., Nicolò, A., Prevenzano, I., Zatterale, F., Longo, M., Desiderio, A., Spinelli, R., Campitelli, M., Conza, D., Raciti, G. A., et al. (2023) · Cells · doi:10.3390/cells12131741 · Cited by 5
“The interest in ADSCs’ use as a therapeutic approach is due to their ability to enhance angiogenesis and accelerate tissue healing [3].”
BackgroundTrufanova, N. A., Hubenia, O., Kot, Y. G., Trufanov, O., Kovalenko, I., Kot, K., & Petrenko, O. (2024) · Biopreservation and Biobanking · doi:10.1089/bio.2024.0103 · Cited by 4
Xia, J., Xu, M., Ma, X., Wang, Z., Shi, X., Zou, H., Xue, Y., Wu, B., Huang, D., Yu, Z., et al. (2025) · Regenesis repair rehabilitation. · doi:10.1016/j.rerere.2025.06.001 · Cited by 6
Alinda, M. D., Christopher, P. M., Listiawan, M. Y., Endaryanto, A., Suroto, H., Rantam, F. A., Hendradi, E., Notobroto, H. B., Menaldi, S. L., & Prakoeswa, C. R. S. (2021) · Bali Medical Journal · doi:10.15562/bmj.v10i3.2747 · Cited by 4
Rodrigues-Ferreira, C., Lopes, J. A., Carneiro, P. F., Lessa, C. D. S., Galina, A., & Vieyra, A. R. (2022) · Cell Transplantation · doi:10.1177/09636897221085883 · Cited by 4
Ray, S. K., & Mukherjee, S. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220425102154 · Cited by 4
Mahmoud, H., Badawy, M., Mohammed, S. A.-N., & Shahawy, M. E. (2024) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2024.106010 · Cited by 4
Updated Applications of Stem Cells in Hypoplastic Left Heart Syndrome
Xiao, R., Darr, H., Khan, Z., & Xiao, Q. (2025) · Cells · doi:10.3390/cells14171396 · Cited by 3
“Instead, BM-MSCs are thought to promote angiogenesis [165], reduce oxidative damage [166], inhibit tissue fibrosis, and prevent cells from apoptosis [167] via paracrine signalling or through the secretion of exosomes.”
Martins, C., Maggio, M., Görgün, C., Brunet, M. Y., Dobricic, M., Almasri, R., O’Brien, F. J., O’Driscoll, L., & Hoey, D. A. (2026) · Advanced Biology · doi:10.1002/adbi.202500544 · Cited by 3
“Different growth factors and cytokines are known to be present, such as VEGF and TGF-β 1 that have been shown to be released by MSCs and promote angiogenesis by activating the PI3K/Akt and MAPK signaling pathways [ 49–51 ].”
Xu, M., Zhang, X., Liu, Y., Yang, Y., Zhou, Z., Ma, J., & Shen, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08030-3 · Cited by 3
“…enhance astrocytic glutamate uptake [95], suppress microglial overactivation, activate neurotrophic pathways such as BDNF-TrkB signaling, and promote VEGF-dependent angiogenesis, thereby helping to restore excitatory-inhibitory balance and synaptic integrity commonly disrupted in ASD [34, 96, 97].”
Habib, S. M., Martini, M. F., Abu-Hamdan, Y. N. H., Shrebaty, O. M. M., & Haider, K. H. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.v18.i3.113871 · Cited by 3
Dangerfield, J. A., & Metzner, C. (2026) · Biomedicines · doi:10.3390/biomedicines14040854 · Cited by 3
Prodromos, C. C., Villar, R. D., Striegel, A., Pena, G. R., & Dixit, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104483 · Cited by 4
“This conceptually makes sense since MSCs can exert their therapeutic effect by secreting EVs that have been shown to mimic the efficacy of MSCs, and exosomes are part of that group of secreted EVs as mentioned before [51,52].”
Navez, M., Barata, E. D. S., Maes, N., Levtchenko, E. N., Arcolino, F. O., Burdeyron, P., Steichen, C., Detry, O., Gilbo, N., & Jouret, F. (2026) · Kidney & Blood Pressure Research · doi:10.1159/000552604 · Cited by 3
Al‐kharboosh, R., Bechtle, A. R., Tzeng, S. Y., Zheng, J., Mondal, S. K., Wilson, D. R., Perez‐Vega, C., Green, J. J., & Quiñones‐Hinojosa, A. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10675 · Cited by 4
“35 Therefore, BMP4 receptor expression at peak time-point (48 h) was investigated.”
Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb Ischemia
Nammian, P., Asadi-Yousefabad, S.-L., Daneshi, S. S., Fallahi, J., Khajeh, S., Tabei, K., & Razban, V. (2025) · MicroRNA · doi:10.2174/0122115366332247250124130611 · Cited by 3
da Rocha, V. P., Mansano, B. S. D. M., dos Santos, C. F. C., Teixeira, I. L. A., de Oliveira, H. A., Vieira, S. S., Antônio, E. L., Izar, M. C. D. O., Fonseca, F. A. H., & Serra, A. J. (2024) · Photochemistry and Photobiology · doi:10.1111/php.13983 · Cited by 3
“42 Therefore, we evaluated cytokines and growth factors secreted by the AdMSCs in response to LED.”
Therapeutic Prospects of Stem Cell-Derived EVs: Upcoming Avenues, Promises, and Challenges
Sharma, Y., Mendiratta, M., & Mohanty, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-2494-9_3 · Cited by 3
Perspectives on Stem Cell Therapy in Diabetic Neuropathic Pain
Montagnoli, T. L., Santos, A. D., Sudo, S. Z., Gubert, F., Vasques, J. F., Méndez‐Otero, R., de Sá, M. P. L., & Zapata‐Sudo, G. (2024) · Neurology International · doi:10.3390/neurolint16050070 · Cited by 5
“Additionally, MSCs also secrete cytokines that promote cell regeneration and neovascularization, potentially improving blood flow and nerve function in DM [61].”
BackgroundStem cell secretome derived from human amniotic fluid affords neuroprotection in an ischemic model
Kingsbury, C., & Stuppia, L. (2021) · Brain Circulation · doi:10.4103/bc.bc_8_21 · Cited by 6
Impact of mesenchymal stem cells derived conditioned media on neural progenitor cells
Humeník, F., Jego, S., Hornakova, L., Maloveská, M., Valenčáková-Agyagosová, A., Vikartovská, Z., Mudroňová, D., Hudáková, N., Žilková, M., & Cizek, D. C. M. (2021) · General Physiology and Biophysics · doi:10.4149/gpb_2021026 · Cited by 3
Kamal, A. A. S., Fakiruddin, K. S., Bobbo, K. A., Ling, K., Vidyadaran, S., & Abdullah, S. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.5.5 · Cited by 3
“Another impressive property of MSC is its ability to be genetically engineered (18), making it flexible as a drug carrier (37) while retaining its stemness characteristics.”
BackgroundHarland, N., Johnen, L., Avula, K. T., Ladinig, A., Schwarz, L., Knoll, J., Stenzl, A., & Aicher, W. K. (2025) · Biomedicines · doi:10.3390/biomedicines13040917 · Cited by 2
“Here, growth factors and cytokines, vascularization, exosomes, activation of resident myogenic progenitor cells (e.g., satellite cells), and other paracrine effects come into play [19,25,27,55–59].”
Dumitru, C. A., Neyazi, B., Kaya, T. A., Stein, K., Rashidi, A., Mawrin, C., & Sandalcioglu, I. E. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10937-1 · Cited by 2
“Although MSCs can release a plethora of factors (reviewed in [ 33 ]), multiple studies demonstrated a critical role of VEGF in MSC-induced angiogenesis [ 34 – 36 ].”
Huang, H., Li, S., Huang, Z., Gong, F., Liu, J., Liu, Z., Li, H., & Yang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-19511-8 · Cited by 2
“Micro-CT analysis revealed that, compared with control treatment, TFRD administration induced more bone formation in the callus at PSD8 (Fig.”
InfluentialMesenchymal stromal cells and their derivatives: A regenerative frontier in burn wound healing
Verma, S. S., Upadhya, R., Bhat, S., & Seetharam, R. N. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153653 · Cited by 2
Russu, M. C. (2023) · Biochemistry · doi:10.5772/intechopen.108010 · Cited by 2
Serack, F. E., Fennell, K. A., Iliopoulos, C., Walker, J. T., Ronald, J. A., Amsden, B. G., Hess, D. A., & Flynn, L. E. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37800 · Cited by 2
Metadata
- Authors
- Maacha, S., Sidahmed, H., Jacob, S., Gentilcore, G., Calzone, R., Grivel, J.-C., & Cugno, C.
- Affiliations
- Sidra Medical and Research Center (QA)
- Corresponding author
- Cugno, Chiara
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2020-03-09
- Volume
- 2020
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC7085399
- OpenAlex
- W3010082761
- Cited by
- 259
- References
- 132
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 46 · 2023: 39 · 2022: 52 · 2021: 53 · 2020: 12
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Qatar National Research Fund (NPRP12S-0304-190225)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, angiogenesis, paracrine signaling, extracellular vesicles, growth factors, cytokines, cell-free therapy, tissue damage, bone marrow-derived MSCs, adipose-derived MSCs, preconditioning, tissue repair, immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.